[Lab] 2th independent test on BCH — 97.8% on a claimed 97.5%, and the trend is the interesting part
Title says it — 2th independent test on BCH — 97.8% on a claimed 97.5%, and the trend is the interesting part — so here is the boring supporting detail that makes it worth anything. The relevant figures are 97.8% and 97.5%, and they come from the same log I have kept the whole time. Watched heart rate on a wearable…
Standing reminder in every thread here: unapproved compound, research material is not for human use, nothing on this board is medical advice.
[deleted]
The injection-site soreness profile felt different rather than worse. Hard to describe and impossible to quantify, so take it as an impression.
Small fix — three receptors, not two. GLP-1, GIP and glucagon, and the third one is the reason this compound gets its own board.
the TRIUMPH programme is still running, so anything definitive is premature
triple agonist — GLP-1, GIP and glucagon, and the glucagon arm is the new part
Correction: TRIUMPH is the phase 3 programme. The number you are quoting is from the phase 2 readout, which is a different trial.
Where the evidence actually stands, since every thread here assumes a different answer.
Phase 2 reported a large mean body weight change at 48 weeks across a few hundred participants with a slow, protocol-driven escalation. The effect size was striking. The confidence intervals were wide, the population was small, and the duration was under a year.
Phase 3 is running. Until it reports, everything else — including the ranking arguments this board loves — is extrapolation from a small study. That is not a criticism of the compound; it is a description of the evidence.
That is body weight change, not fat mass. The trials report the first and people quote it as the second.
research-use-only material is not approved for human use, full stop
a lot of the confident posting here is extrapolation